QUANTRO Therapeutics
PrivateLast Round
Seed
Jul 21, 2020
Company Overview
QUANTRO Therapeutics operates in Healthcare & Life Sciences and is based in Vienna. Its latest recorded funding round was a Seed round in July 2020.
QUANTRO Therapeutics is a biotechnology company that discovers and develops novel therapeutics interfering with disease-causing transcriptional programs in cancer and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Platform-as-a-Service
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
QUANTRO Therapeutics Comparables
Compare QUANTRO Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Proxygen | 86% | |
| Talus Bio | 84% | |
| RIANA Therapeutics | 83% |
For institutional investors. Book with your work email.
QUANTRO Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
QUANTRO Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boehringer Ingelheim | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 13, 2023
Grew 30% QoQ from 10 to 13 employees.
- Nov 24, 2023
Grew 30% QoQ, from 10 to 13 employees.
For institutional investors. Book with your work email.
QUANTRO Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about QUANTRO Therapeutics's valuation, stock price, and market status.
Is QUANTRO Therapeutics a public or private company?
QUANTRO Therapeutics is a private company.
What is the current stock price of QUANTRO Therapeutics?
QUANTRO Therapeutics is a private company, so its shares have no public market price. Caplight tracks QUANTRO Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is QUANTRO Therapeutics worth (valuation)?
Valuation information for QUANTRO Therapeutics is not publicly available.
Can I buy QUANTRO Therapeutics stock?
QUANTRO Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was QUANTRO Therapeutics's last funding round?
QUANTRO Therapeutics's most recent funding round was Seed on July 21, 2020.
Who are the main investors in QUANTRO Therapeutics?
Key investors in QUANTRO Therapeutics include Boehringer Ingelheim.
Will QUANTRO Therapeutics IPO soon?
No public IPO plans have been announced for QUANTRO Therapeutics.
How can I track QUANTRO Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in QUANTRO Therapeutics's shares on secondary markets.